Kwality Pharmaceuticals P/B Ratio

Current P/B Ratio
11.02
High Valuation
Very High - Significant premium, high growth expectations or speculative

Kwality Pharmaceuticals (KPL) P/B ratio is 11.02 (High), book value per share ₹330.00 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Read KPL dividend history for the complete payout history and dividend yield track record.

Current Valuation Metrics

P/B Ratio 11.02
Current Price ₹3471.20
Book Value/Share ₹330.00
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹330 Cr
Share Capital ₹10 Cr
Reserves & Surplus ₹321 Cr
Outstanding Shares 10,000,000
Book Value per Share ₹330.00

Valuation Signal

Signal Overvalued
Historical Avg 4.55
Historical Range 2.01 - 10.52
Percentile 100.0%

Sector Context

Sector Average -0.01
Sector Median 0.62
Sector Rank #11 of 50
Sector Percentile 22.0%

KPL P/B Ratio — Valuation Insights & Book Value Analysis

Kwality Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 11.02 (High). For live price, earnings yield and the full fundamental profile, see KPL share price screener.

  • Stock appears overvalued with PB of 11.02, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 142.1% above historical average
  • Trading at premium to sector average PB of -0.01

Kwality Pharmaceuticals P/B Ratio Historical Trend

KPL annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Explore KPL value investing to estimate fundamental worth using multiple valuation models.

KPL Historical P/B Ratio — Book Value Per Share & Year-End Price

Kwality Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 10.52 ₹330.0 ₹3471.20 ₹330 High
2025 4.23 ₹262.0 ₹1108.35 ₹262 High
2024 3.89 ₹223.0 ₹866.80 ₹223 High
2023 2.01 ₹199.0 ₹399.80 ₹199 Moderate
2022 2.11 ₹180.0 ₹379.80 ₹180 Moderate

KPL vs Healthcare Peers — P/B Ratio Comparison

Kwality Pharmaceuticals P/B 11.02 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.

Sector Average
-0.01
Sector Median
0.62
Lowest P/B
-6.55
Highest P/B
1.09
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.0 ₹65 Low
Krebs Biochemicals & Ind… KREBSBIO -0.82 ₹129 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.21 ₹50 Low
Triochem Products TRIPR 0.04 ₹0 Low